(Reuters) – The U.S. Food and Drug Administration (FDA) decided on Thursday night to approve Moderna Inc’s coronavirus vaccine on an emergency basis, the Financial Times reported https://www.ft.com/content/bab87cb7-0e4d-4650-90db-49803189cee4, citing people close to the process.
The report comes after the FDA said it informed Moderna that it would rapidly work towards the finalization and issuance of emergency use authorization (EUA) for its COVID-19 vaccine candidate, according to commissioner Stephen Hahn.
(Reporting by Shubham Kalia in Bengaluru; Editing by Aditya Soni)
